Compare ECPG & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ECPG | RAPP |
|---|---|---|
| Founded | 1998 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1999 | 2024 |
| Metric | ECPG | RAPP |
|---|---|---|
| Price | $55.21 | $30.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $59.50 | $47.80 |
| AVG Volume (30 Days) | 241.6K | ★ 412.2K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,560,869,000.00 | N/A |
| Revenue This Year | $32.56 | N/A |
| Revenue Next Year | $3.04 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.52 | N/A |
| 52 Week Low | $26.45 | $6.43 |
| 52 Week High | $56.67 | $42.27 |
| Indicator | ECPG | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 64.12 | 55.51 |
| Support Level | $53.95 | $28.99 |
| Resistance Level | $55.72 | $31.52 |
| Average True Range (ATR) | 1.48 | 1.88 |
| MACD | -0.20 | -0.04 |
| Stochastic Oscillator | 63.72 | 54.51 |
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.